Results 191 to 200 of about 767,524 (260)
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi +14 more
wiley +1 more source
Contributing factors to declining vaccination campaign quality and resurgence of polio cases in Quetta block, Pakistan: a five-year analysis (2020-2024). [PDF]
Larik E +7 more
europepmc +1 more source
Exploring ethical dilemmas in the care of pregnant women in Ghana: a case of "maternal-foetal conflicts in a peri-urban hospital in Ghana". [PDF]
Haruna Z, Amoakoh-Coleman M.
europepmc +1 more source
Decisional Conflict About Contralateral Prophylactic Mastectomy in Patients with Breast Cancer with and Without Pathogenic Variants in <i>BRCA</i> Genes. [PDF]
Sung JH, Katapodi MC, Park SY.
europepmc +1 more source
Fertility intentions among medical students in war-torn Ukraine: a cross-sectional survey. [PDF]
Mogilevkina I +4 more
europepmc +1 more source
Contraceptive access in displacement settings: a quantitative study of Syrians displaced to Türkiye. [PDF]
Le Voir R.
europepmc +1 more source

